PRINCETON, N.J., March 08, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company today reported financial results for the three months and year ended December 31, 2016 and provided a corporate update for the fourth quarter 2016.
Fourth quarter 2016 and other recent corporate developments include:
* In December 2016, the Company announced that it had received net proceeds of approximately $3.0 million in non-dilutive financing through the State of New Jersey’s Technology Business Tax Certificate Transfer Program.
